Sign Up Today and Learn More About Moyang Biotechnology Stock
Invest in or calculate the value of your shares in Moyang Biotechnology or other pre-IPO companies through EquityZen's platform.
Moyang Biotechnology Stock (MOYB)
Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
About Moyang Biotechnology Stock
Founded
2018
Industries
Software, Artificial Intelligence, Science and Engineering
Moyang Biotechnology Press Mentions
Stay in the know about the latest news on Moyang Biotechnology
Aphranel® Marks First Anniversary with EU MDR Certification, Arc™ Launch, and Over 150,000 Syringes Delivered
morningstar • Jun 05, 2026
Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable
prnewswire • May 28, 2026
Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning
prnewswire • Jan 26, 2026
Aphranel Convenes Cadaver Dissection Class in Thailand Successfully
prnewswire • Jan 16, 2026
Nutraland USA and Youthorin Biotechnology Form Strategic Partnership to Advance Next-Generation Health Ingredients
einpresswire • Aug 19, 2025
Join now and verify your accreditation status to gain access to:
- Moyang Biotechnology Current Valuation
- Moyang Biotechnology Stock Price
- Moyang Biotechnology Management
- Available deals in Moyang Biotechnology and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Moyang Biotechnology Cap Table and Funding History by Share Class and Liquidity Preferences
- Moyang Biotechnology Revenue and Financials
- Moyang Biotechnology Highlights
- Moyang Biotechnology Business Model
- Moyang Biotechnology Risk Factors
- Moyang Biotechnology Research Report from SACRA Research
Trading Moyang Biotechnology Stock
How to invest in Moyang Biotechnology stock?
Accredited investors can buy pre-IPO stock in companies like Moyang Biotechnology through EquityZen funds. These investments are made available by existing Moyang Biotechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Moyang Biotechnology stock?
Shareholders can sell their Moyang Biotechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
